We've Added Something New

Well, we have added a new element in our little adventure into the unknown. My doctor called yesterday and asked if I would be willing to participate in a clinical trial with a new drug which has not yet been named, but is identified as MKC-1. This is an experimental drug that has shown some promise in enhancing treatment when paired with Alimta. As with anything else there are some risks, but the potential benefits seem to outweigh the risks. I will be monitored closely (twice a week) during this process and will have blood tests at least twice a week. So, if at any point undesirable results are detected we will stop the treatment with MKC-1. The drug is taken as a pill, twice daily for a period of 14 days. There is a 7 day rest period and then the cycle begins again. The Alimta treatments will be once every three weeks, so the MKC-1 is on the same cycle. The clinical trial is sponsored by EntreMed. You can get information off their web site and there is also information on ClinicalTrials.gov. We'll keep you posted.